Skip to main content
ChemPartner PharmaTech Co., Ltd. logo

ChemPartner PharmaTech Co., Ltd. — Investor Relations & Filings

Ticker · 300149 ISIN · CNE100000Y27 Shenzhen Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 2,256 across all filing types
Latest filing 2018-07-31 Declaration of Voting R…
Country CN China
Listing Shenzhen Stock Exchange 300149

About ChemPartner PharmaTech Co., Ltd.

https://www.chempartner.com

ChemPartner PharmaTech Co., Ltd. is a global research and development organization providing comprehensive drug discovery and development services. Operating as a Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO), the company supports pharmaceutical and biotechnology clients through an integrated service platform. Core capabilities include medicinal chemistry, biology, pharmacology, drug metabolism and pharmacokinetics (DMPK), and toxicology. The organization also offers specialized expertise in biologics discovery, protein engineering, and antibody development. ChemPartner facilitates the transition from early-stage research to clinical development through its pharmaceutical development and manufacturing capabilities, utilizing advanced technology to accelerate the discovery and production of novel therapeutic agents.

Recent filings

Filing Released Lang Actions
2018年第三次临时股东大会的法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the 2018 third extraordinary general meeting (临时股东大会) of Quantum Hi-Tech (China) Biological Co., Ltd. It details the legality and compliance of the meeting's convening, attendance, voting procedures, and results. The document includes detailed voting results on various proposals, including board member elections and amendments to company rules. It is not a financial report, earnings release, or management discussion, but a legal opinion on the shareholder meeting process and outcomes. This type of document corresponds to a Declaration of Voting Results & Voting Rights Announcements (DVA), as it officially reports the voting results of a shareholders' meeting.
2018-07-31 Chinese
关于召开2018年第三次临时股东大会的提示性公告
AGM Information Classification · 95% confidence The document is a detailed announcement regarding the convening of the 2018 third extraordinary general meeting of shareholders for Quantum Hi-Tech (China) Biological Co., Ltd. It includes information about the meeting date, voting procedures (both in-person and online), agenda items including election of board members and auditors, amendments to company bylaws, and other governance matters. It also contains attachments such as the proxy form and shareholder registration form. The content focuses on informing shareholders about the meeting logistics and agenda, not the results of voting or the meeting itself. This type of document is a notice or announcement related to a shareholders' meeting, specifically an Extraordinary General Meeting (EGM) notice. It is not a report of voting results, nor is it a management report or financial statement. Therefore, the best fitting category is AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting or similar shareholder meetings, including notices and announcements about such meetings. The document length (7643 characters) and detailed procedural content confirm it is a meeting notice rather than a brief announcement or a report publication announcement.
2018-07-27 Chinese
关于控股股东工商信息变更的公告
Regulatory Filings Classification · 90% confidence The document is an announcement regarding changes in the business registration information of the company's controlling shareholder, including name, address, registered capital, and business scope. It explicitly states that there is no change in shareholding structure or control. The document is short (1054 characters) and does not contain financial data, audit information, or management discussion. It is not a report or financial statement but a regulatory announcement about shareholder-related information. This fits the category of Major Shareholding Notification (MRQ) or Board/Management Information (MANG). However, since it concerns changes in the controlling shareholder's business registration details rather than direct changes in board or management personnel, it is best classified as a Regulatory Filing (RNS) as a fallback for miscellaneous regulatory announcements that do not fit other categories.
2018-07-19 Chinese
关于召开2018年第三次临时股东大会的通知（更新后）
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a detailed notice for the 2018 third extraordinary general meeting of shareholders of Quantum Hi-Tech (China) Biological Co., Ltd. It includes information about the meeting date, agenda items such as election of board members and supervisors, amendments to company bylaws, and procedures for voting including online voting. It also contains attachments like proxy forms and shareholder registration forms. The content is focused on informing shareholders about the meeting and soliciting their votes on various proposals. There is no financial data, earnings information, or audit results presented. The document is not a report itself but a formal announcement and notice for a shareholders meeting, including voting instructions and agenda. Therefore, it fits the category of Proxy Solicitation & Information Statement (PSI), which covers materials sent to shareholders to provide information and request votes for meetings.
2018-07-16 Chinese
关于召开2018年第三次临时股东大会的通知的更正公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a correction announcement regarding the notice for convening the 2018 third extraordinary general meeting of shareholders of Quantum Hi-Tech (China) Biological Co., Ltd. It details corrections to the voting procedures and proxy forms related to the shareholder meeting. The content focuses on procedural and administrative details for shareholder voting and proxy authorization, which are typical for announcements related to shareholder meetings. There is no financial data, earnings information, or management discussion present. The document is not the meeting materials themselves but a correction to the notice of the meeting. Therefore, it fits best under the category of Declaration of Voting Results & Voting Rights Announcements (DVA), as it relates to shareholder voting procedures and proxy information for a general meeting.
2018-07-16 Chinese
关于更换会计师事务所的公告
Audit Report / Information Classification · 95% confidence The document is an announcement regarding the change of the company's auditor for the 2018 fiscal year. It details the decision process, including board and supervisory committee approvals, and the appointment of a new accounting firm (PwC Zhongtian). The document does not contain any financial statements or audit results but is a formal notice about the auditor change. It is not an audit report itself, nor an annual or interim report. Given the content and length (1912 characters), it fits the category of an announcement related to audit matters but not the audit report itself. Therefore, it is best classified as an Audit Report / Information (AR) type, which covers standalone audit-related announcements excluding full reports.
2018-07-13 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.